Diosgenin enhances 5-fluorouracil sensitivity in drug-resistant colorectal cancer cells via inhibition of ATR/Chk1-mediated DNA damage response.
The findings of this study suggest that diosgenin may contribute to reducing 5-FU resistance by affecting ATR/CHK1-associated DNA damage response mechanisms, weakening DNA repair mechanisms, and suppressing drug efflux pumps.